Movement Alert|Aehr Test falls 5.19% in Regular Trading, post-earnings momentum continues to cool after prior AI testing rally

Market Focus11-13

On November 13, Aehr Test falls 5.19% in Regular Trading, trading at $57.96/share, with turnover of $17.6366 million.

The move followed continued cooling in the market’s post-earnings trading momentum after investors had previously bid up the stock on stronger-than-expected quarterly results, a higher full-year revenue outlook, and progress in AI chip testing orders and deployments.

Previously disclosed results showed adjusted first-quarter EPS of $0.28 versus expectations of $0.11 and revenue of $33.007 million versus $27.072 million expected. The company also reported backlog of $100.9 million as of September 25 and highlighted deployment progress with a major AI accelerator customer, including a fully configured FOX-XP wafer-level burn-in system planned for installation at a partner facility in Taiwan in early 2027. After the earlier sharp rally, the marginal boost from those positives appears to have faded, with trading turning more cautious.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment